{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:38:44Z","timestamp":1794739124034,"version":"4.9.1"},"reference-count":101,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Chlorotoxin (CTX) is a 36-amino-acid disulfide-containing peptide derived from the venom of the scorpion Leiurus quinquestriatus. CTX alters physiology in numerous ways. It interacts with voltage gated chloride channels, Annexin-2, and matrix metalloproteinase-2 (MMP-2). CTX-based bioconjugates have been widely subjected to phase I\/II clinical trials and have shown substantial promise. Many studies have demonstrated that CTX preferentially binds to neuroectodermal tumors, such as glioblastoma, without cross-reactivity to normal brain cells. With its ability to penetrate the blood-brain-barrier (BBB) and its tyrosine residue allows covalent conjugation with functional moieties, CTX is an attractive platform to explore development of diagnostic and therapeutic agents for gliomas. In this review, we outline CTX structure and its molecular targets, summarize molecular variations of CTX developed for glioma imaging, and discuss future trends and perspectives for CTX conjugates as a theranostic agent.<\/jats:p>","DOI":"10.3390\/toxins10120496","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T03:31:33Z","timestamp":1543289493000},"page":"496","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Chlorotoxin\u2014A Multimodal Imaging Platform for Targeting Glioma Tumors"],"prefix":"10.3390","volume":"10","author":[{"given":"Gadi","family":"Cohen","sequence":"first","affiliation":[{"name":"Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott R.","family":"Burks","sequence":"additional","affiliation":[{"name":"Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Frank","sequence":"additional","affiliation":[{"name":"Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA"},{"name":"National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1158\/1055-9965.EPI-14-0275","article-title":"Epidemiologic and molecular prognostic review of glioblastoma","volume":"23","author":"Thakkar","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","article-title":"CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012","volume":"17","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2009\u20132013","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.6004\/jnccn.2017.0166","article-title":"NCCN clinical practice guidelines in oncology: Central nervous system cancers","volume":"15","author":"Nabors","year":"2014","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Wilson, T.A., Karajannis, M.A., and Harter, D.H. (2014). Glioblastoma multiforme: State of the art and future therapeutics. Surg. Neurol. Int., 5.","DOI":"10.4103\/2152-7806.132138"},{"key":"ref_6","unstructured":"Hayat, M.A. (2011). Impact of Extent of Resection on Outcomes in Patients with High-Grade Gliomas, Springer."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zhao, S., Wu, J., Wang, C., Liu, H., Dong, X., Shi, C., Shi, C., Liu, Y., Teng, L., and Han, D. (2013). Intraoperative fluorescence-guided resection of high-grade malignant gliomas using 5-Aminolevulinic scid-induced porphyrins: A dystematic review and meta-analysis of prospective studies. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063682"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.bjc.6606031","article-title":"Gene expression profiling of gliomas: Merging genomic and histopathological classification for personalised therapy","volume":"104","author":"Vitucci","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_10","first-page":"4871","article-title":"Use of chlorotoxin for targeting of primary brain tumors","volume":"58","author":"Soroceanu","year":"1998","journal-title":"Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.23-13-05572.2003","article-title":"Expression of voltage-gated chloride channels in human glioma cells","volume":"23","author":"Olsen","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S1740925X06000044","article-title":"A role for ion channels in glioma cell invasion","volume":"2","author":"McFerrin","year":"2006","journal-title":"Neuron Glia Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1016\/j.biomaterials.2014.03.077","article-title":"The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3","volume":"35","author":"Qin","year":"2014","journal-title":"Biomaterials"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jocn.2016.04.012","article-title":"Glioblastoma multiforme targeted therapy: The Chlorotoxin story","volume":"33","author":"Zaaroor","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/bip.22748","article-title":"Chlorotoxin: Structure, activity, and potential uses in cancer therapy","volume":"106","author":"Ojeda","year":"2016","journal-title":"Biopolymers"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/bi00001a003","article-title":"NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channels","volume":"34","author":"Lippens","year":"1995","journal-title":"Biochemistry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1021\/jm101018r","article-title":"Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy","volume":"54","author":"Akcan","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"C361","DOI":"10.1152\/ajpcell.1993.264.2.C361","article-title":"Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion","volume":"264","author":"DeBin","year":"1993","journal-title":"Am. J. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7756","DOI":"10.1021\/bi00149a003","article-title":"Analysis of side-chain organization on a refined model of charybdotoxin: Structural and functional implications","volume":"31","author":"Bontems","year":"1992","journal-title":"Biochemistry"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0306-4522(97)00456-9","article-title":"Expression of voltage-activated chloride currents in acute slices of human gliomas","volume":"83","author":"Ullrich","year":"1998","journal-title":"Neuroscience"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"C1290","DOI":"10.1152\/ajpcell.1997.273.4.C1290","article-title":"Cell cycle-dependent expression of a glioma-specific chloride current: Proposed link to cytoskeletal changes","volume":"273","author":"Ullrich","year":"1997","journal-title":"Am. J. Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"20130095","DOI":"10.1098\/rstb.2013.0095","article-title":"Cl\u2212 and K+ channels and their role in primary brain tumour biology","volume":"369","author":"Turner","year":"2014","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/sj.bjp.0703102","article-title":"Chlorotoxin does not inhibit volume-regulated, calcium-activated and cyclic AMP-activated chloride channels","volume":"129","author":"Maertens","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12307-011-0064-9","article-title":"The role of annexin A2 in tumorigenesis and cancer progression","volume":"4","author":"Lokman","year":"2011","journal-title":"Cancer Microenviron."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1358\/dof.2011.36.8.1656504","article-title":"Targeted antitumor therapy with the scorpion venom chlorotoxin","volume":"36","author":"Mamelak","year":"2011","journal-title":"Drugs Future"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1074\/jbc.M109.066092","article-title":"Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects","volume":"285","author":"Kesavan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2990.2006.00720.x","article-title":"Knockdown of annexin 2 decreases migration of human glioma cells in vitro","volume":"32","author":"Tatenhorst","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"100908","DOI":"10.18632\/oncotarget.21740","article-title":"Venom-based peptide therapy: Insights into anti-cancer mechanism","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.toxicon.2014.11.233","article-title":"Scorpion venom components as potential candidates for drug development","volume":"93","author":"Ortiz","year":"2015","journal-title":"Toxicon"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Banerji","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.drudis.2014.10.016","article-title":"PET, MRI, and simultaneous PET\/MRI in the development of diagnostic and therapeutic strategies for glioma","volume":"20","author":"Puttick","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3390\/toxins7041079","article-title":"Chlorotoxin: A helpful natural scorpion peptide to diagnose glioma and fight tumor invasion","volume":"7","author":"Dardevet","year":"2015","journal-title":"Toxins"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11060-011-0763-6","article-title":"Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs","volume":"107","author":"Fu","year":"2012","journal-title":"J. Neurooncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-004-0890-4","article-title":"Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice","volume":"71","author":"Shen","year":"2005","journal-title":"J. Neurooncol."},{"key":"ref_36","first-page":"580","article-title":"Imaging glioma extent with 131I-TM-601","volume":"46","author":"Hockaday","year":"2005","journal-title":"J. Nucl. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2005.05.4569","article-title":"Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma","volume":"24","author":"Mamelak","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/17425247.4.2.175","article-title":"Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)","volume":"4","author":"Mamelak","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"19798","DOI":"10.1021\/acsami.5b05836","article-title":"Chlorotoxin-conjugated multifunctional dendrimers labeled with radionuclide 131I for single photon emission computed tomography imaging and radiotherapy of gliomas","volume":"7","author":"Zhao","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2217\/nnm.14.1","article-title":"Targeted delivery of silver nanoparticles and alisertib: In vitro and in vivo synergistic effect against glioblastoma","volume":"9","author":"Locatelli","year":"2014","journal-title":"Nanomedicine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.3892\/mmr.2017.6284","article-title":"BmK CT and 125I-BmK CT suppress the invasion of glioma cells in vitro via matrix metalloproteinase-2","volume":"15","author":"Sun","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"626","DOI":"10.5732\/cjc.009.10359","article-title":"Development of the research on the application of chlorotoxin in imaging diagnostics and targeted therapies for tumors","volume":"29","author":"Wu","year":"2010","journal-title":"Chin. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: A chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ab.2013.05.013","article-title":"Characterization of IRDye 800CW chlorotoxin as a targeting agent for brain tumors","volume":"440","author":"Kovar","year":"2013","journal-title":"Anal. Biochem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/anie.201007461","article-title":"Design of highly emissive polymer dot bioconjugates for in vivo tumor targeting","volume":"50","author":"Wu","year":"2011","journal-title":"Angew. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1016\/j.biomaterials.2010.07.099","article-title":"Neurotoxin-conjugated upconversion nanoprobes for direct visualization of tumors under near-infrared irradiation","volume":"31","author":"Yu","year":"2010","journal-title":"Biomaterials"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"60612","DOI":"10.1039\/C5RA11250H","article-title":"Thermal decomposition based synthesis of Ag-In-S\/ZnS quantum dots and their chlorotoxin-modified micelles for brain tumor cell targeting","volume":"74","author":"Chen","year":"2015","journal-title":"RSC Adv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3171\/2013.11.FOCUS13497","article-title":"Near-infrared imaging of brain tumors using the tumor paint BLZ-100 to achieve near-complete resection of brain tumors","volume":"36","author":"Butte","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"8032","DOI":"10.1016\/j.biomaterials.2010.07.016","article-title":"Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery","volume":"31","author":"Veiseh","year":"2010","journal-title":"Biomaterials"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.biomaterials.2008.10.003","article-title":"A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells","volume":"30","author":"Veiseh","year":"2009","journal-title":"Biomaterials"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2217\/17435889.3.4.495","article-title":"Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles","volume":"3","author":"Sun","year":"2008","journal-title":"Nanomedicine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1021\/nn1008512","article-title":"Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma","volume":"4","author":"Kievit","year":"2010","journal-title":"ACS Nano"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"235104","DOI":"10.1088\/0957-4484\/21\/23\/235104","article-title":"Incorporation of magnetite nanoparticle clusters in fluorescent silica nanoparticles for high-performance brain tumor delineation","volume":"21","author":"Wan","year":"2010","journal-title":"Nanotechnology"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Lee, M.J.E., Veiseh, O., Bhattarai, N., Sun, C., Hansen, S.J., Ditzler, S., Knoblaugh, S., Lee, D., Ellenbogen, R., and Zhang, M. (2010). Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: A novel non-radioactive method. PLoS ONE, 5.","DOI":"10.1371\/annotation\/aab4514c-8393-4f1c-a482-fd2008da36ac"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/smll.200700784","article-title":"In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes","volume":"4","author":"Sun","year":"2008","journal-title":"Small"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/nl0502569","article-title":"Optical and MRI multifunctional nanoprobe for targeting gliomas","volume":"5","author":"Veiseh","year":"2005","journal-title":"Nano Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1039\/C3TB21613F","article-title":"Ho3+ doped NaGdF4 nanoparticles as MRI\/optical probes for brain glioma imaging","volume":"2","author":"Deng","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1016\/j.biomaterials.2011.03.075","article-title":"Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis","volume":"32","author":"Huang","year":"2011","journal-title":"Biomaterials"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/bc200151q","article-title":"Theranostics: Combining imaging and therapy","volume":"22","author":"Kelkar","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MNM.0b013e3282f3a515","article-title":"PET versus SPECT: Strengths, limitations and challenges","volume":"29","author":"Rahmim","year":"2008","journal-title":"Nucl. Med. Commun."},{"key":"ref_61","first-page":"385","article-title":"Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates","volume":"4","author":"Cheng","year":"2014","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Lebdukov\u00e1, P., Sour, A., Helm, L., T\u00f3th, \u00c9., Kotek, J., Luke, I., and Merbach, A.E. (2006). Phosphinic derivative of DTPA conjugated to a G5 PAMAM dendrimer: An17O and1H relaxation study of its Gd(III) complex. Dalt. Trans., 3399\u20133406.","DOI":"10.1039\/B517847A"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmat2398","article-title":"Biodegradable luminescent porous silicon nanoparticles for in vivo applications","volume":"8","author":"Park","year":"2009","journal-title":"Nat. Mater."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.rli.0000197669.80475.dd","article-title":"Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent","volume":"41","author":"Bourrinet","year":"2006","journal-title":"Invest. Radiol."},{"key":"ref_65","first-page":"509","article-title":"Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors","volume":"23","author":"Varallyay","year":"2002","journal-title":"Am. J. Neuroradiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jcis.2014.07.013","article-title":"Synthesis, characterization, and cellular uptake of magnetic nanocarriers for cancer drug delivery","volume":"1","author":"Momtazi","year":"2014","journal-title":"J. Colloid Interface Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1039\/C6NR00147E","article-title":"Application of iron oxide nanoparticles in glioma imaging and therapy: From bench to bedside","volume":"8","author":"Liu","year":"2016","journal-title":"Nanoscale"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s11095-012-0679-7","article-title":"Magnetic nanoparticles for cancer diagnosis and therapy","volume":"29","author":"Yigit","year":"2012","journal-title":"Pharm. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"15982","DOI":"10.1021\/ja066547g","article-title":"Biocompatible heterostructured nanoparticles for multimodal biological detection","volume":"128","author":"Choi","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.2174\/1568026615666150330110822","article-title":"Chlorotoxin-conjugated nanoparticles for targeted imaging and therapy of glioma","volume":"15","author":"Zhao","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/smll.200800646","article-title":"Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles","volume":"5","author":"Veiseh","year":"2009","journal-title":"Small"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1158\/0008-5472.CAN-09-1157","article-title":"Specific targeting of brain tumors with an optical\/magnetic resonance imaging nanoprobe across the blood-brain barrier","volume":"69","author":"Veiseh","year":"2009","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.bmc.2017.09.039","article-title":"Peptides for optical medical imaging and steps towards therapy","volume":"26","author":"Staderini","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.271.5251.933","article-title":"Semiconductor clusters, nanocrystals, and quantum dots","volume":"271","author":"Alivisatos","year":"1996","journal-title":"Science"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"290","DOI":"10.7150\/thno.7341","article-title":"Radiolabeled nanoparticles for multimodality tumor imaging","volume":"4","author":"Xing","year":"2014","journal-title":"Theranostics"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1021\/nl8032284","article-title":"High affinity scFv-hapten pair as a tool for quantum dot labeling and tracking of single proteins in live cells","volume":"8","author":"Iyer","year":"2008","journal-title":"Nano Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1126\/science.281.5385.2013","article-title":"Semiconductor nanocrystals as fluorescent biological labels","volume":"281","author":"Bruchez","year":"1998","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nano.2010.12.006","article-title":"Quantum dots, lighting up the research and development of nanomedicine","volume":"7","author":"Wang","year":"2011","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/smll.200900626","article-title":"In vivo quantum-dot toxicity assessment","volume":"6","author":"Hauck","year":"2010","journal-title":"Small"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/nnm.11.19","article-title":"Nanoparticle PEGylation for imaging and therapy","volume":"6","author":"Jokerst","year":"2011","journal-title":"Nanomedicine"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1289\/ehp.8284","article-title":"A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors","volume":"114","author":"Hardman","year":"2006","journal-title":"Environ. Health Perspect."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cbpa.2010.08.014","article-title":"Upconverting luminescent nanoparticles for use in bioconjugation and bioimaging","volume":"14","author":"Mader","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.2174\/138161211798999375","article-title":"In vivo bio-imaging using chlorotoxin-based conjugates","volume":"17","author":"Stroud","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"041101","DOI":"10.1063\/1.2195024","article-title":"Photoacoustic imaging in biomedicine","volume":"77","author":"Xu","year":"2006","journal-title":"Rev. Sci. Instrum."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Bost, W., and Fournelle, M. (2013). Molecular imaging of glioblastoma cells using functionalized nanorods and a high resolution optoacoustic microscope. IEEE Int. Ultrason. Symp. IUS, 120\u2013123.","DOI":"10.1109\/ULTSYM.2013.0031"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"10510","DOI":"10.1117\/1.3302808","article-title":"Multifunctional microbubbles and nanobubbles for photoacoustic and ultrasound imaging","volume":"15","author":"Kim","year":"2010","journal-title":"J. Biomed. Opt."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/02656736.2015.1009179","article-title":"An overview of the influence of therapeutic ultrasound exposures on the vasculature: High intensity ultrasound and microbubble-mediated bioeffects","volume":"31","author":"Goertz","year":"2015","journal-title":"Int. J. Hyperth."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1517\/17425247.4.5.475","article-title":"The application of microbubbles for targeted drug delivery","volume":"4","author":"Bull","year":"2007","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2005.11.006","article-title":"Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles","volume":"111","author":"Lum","year":"2006","journal-title":"J. Control. Release"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(03)00627-2","article-title":"Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction","volume":"42","author":"Chen","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ultrasmedbio.2007.12.015","article-title":"Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium","volume":"34","author":"Sheikov","year":"2008","journal-title":"Ultrasound Med. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1148\/radiol.2202001804","article-title":"Noninvasive MR imaging\u2013guided focal opening of the blood-brain barrier in rabbits","volume":"220","author":"Hynynen","year":"2001","journal-title":"Radiology"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.7150\/thno.24181","article-title":"Focused ultrasound with microbubbles induces sterile inflammatory response proportional to the blood brain barrier opening: Attention to experimental conditions","volume":"8","author":"Kovacs","year":"2018","journal-title":"Theranostics"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1073\/pnas.1614777114","article-title":"Disrupting the blood\u2013brain barrier by focused ultrasound induces sterile inflammation","volume":"114","author":"Kovacs","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2147\/IJN.S29229","article-title":"Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound","volume":"7","author":"Yang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.biomaterials.2011.09.096","article-title":"Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment","volume":"33","author":"Ting","year":"2012","journal-title":"Biomaterials"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2147\/IJN.S28503","article-title":"Evaluation of the increase in permeability of the blood-brain barrier during tumor progression after pulsed focused ultrasound","volume":"7","author":"Yang","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ultras.2008.04.004","article-title":"Progress and problems in the application of focused ultrasound for blood-brain barrier disruption","volume":"48","author":"Vykhodtseva","year":"2008","journal-title":"Ultrasonics"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ultrasmedbio.2012.11.027","article-title":"Evaluation of dose distribution of molecular delivery after blood-brain barrier disruption by focused ultrasound with treatment planning","volume":"39","author":"Yang","year":"2013","journal-title":"Ultrasound Med. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Yang, F.Y., Ko, C.E., Huang, S.Y., Chung, I.F., and Chen, G.S. (2014). Pharmacokinetic changes induced by focused ultrasound in glioma-bearing rats as measured by dynamic contrast-enhanced MRI. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092910"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2011.03.014","article-title":"Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes","volume":"152","author":"Xiang","year":"2011","journal-title":"J. Control. Release"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/10\/12\/496\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:32:05Z","timestamp":1760196725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/10\/12\/496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":101,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["toxins10120496"],"URL":"https:\/\/doi.org\/10.3390\/toxins10120496","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]}}}